Patents by Inventor Andrew Stuart Lister

Andrew Stuart Lister has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Autotaxin inhibitors
    Patent number: 10183025
    Abstract: The present invention relates to novel compounds that are autotaxin inhibitors, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in diseases and disorders mediated by autotaxin.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: January 22, 2019
    Assignee: Novartis AG
    Inventors: David Beattie, Urs Baettig, Darren Mark Le Grand, Andrew Stuart Lister, Jeffrey McKenna, David William Pearce, David Andrew Sandham, Oliver Ross Steward, Christopher Thomson
  • AUTOTAXIN INHIBITORS
    Publication number: 20180021345
    Abstract: The present invention relates to novel compounds that are autotaxin inhibitors, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in diseases and disorders mediated by autotaxin.
    Type: Application
    Filed: August 9, 2017
    Publication date: January 25, 2018
    Applicant: Novartis AG
    Inventors: David BEATTIE, Urs BAETTIG, Darren Mark LE GRAND, Andrew Stuart LISTER, Jeffrey MCKENNA, David William PEARCE, David Andrew SANDHAM, Oliver Ross STEWARD, Christopher THOMSON
  • Autotaxin inhibitors
    Patent number: 9763957
    Abstract: The present invention relates to novel compounds that are autotaxin inhibitors, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in diseases and disorders mediated by autotaxin.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: September 19, 2017
    Assignee: Novartis AG
    Inventors: David Beattie, Urs Baettig, Darren Mark Legrand, Andrew Stuart Lister, Jeffrey McKenna, David William Pearce, David Andrew Sandham, Oliver Ross Steward, Christopher Thomson
  • AUTOTAXIN INHIBITORS
    Publication number: 20160184318
    Abstract: The present invention relates to novel compounds that are autotaxin inhibitors, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in diseases and disorders mediated by autotaxin.
    Type: Application
    Filed: July 16, 2014
    Publication date: June 30, 2016
    Applicant: Novartis AG
    Inventors: David BEATTIE, Urs BAETTIG, Darren Mark LEGRAND, Andrew Stuart LISTER, Jeffrey MCKENNA, David William PEARCE, Ddavid Andrew SANDHAM, Oliver Ross STEWARD, Christopher Thomson
  • AUTOTAXIN INHIBITORS
    Publication number: 20160168119
    Abstract: The present invention relates to novel compounds that are autotaxin inhibitors, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in diseases and disorders mediated by autotaxin.
    Type: Application
    Filed: July 16, 2014
    Publication date: June 16, 2016
    Applicant: Novartis AG
    Inventors: Urs BAETTIG, David BEATTIE, Darren Mark LEGRAND, Andrew Stuart LISTER, Jeffrey MCKENNA, David William PEARCE, David Andrew SANDHAM, Emily STANLEY, Oliver Ross STEWARD, Christopher THOMSON
  • Compouds
    Publication number: 20120322788
    Abstract: The present invention relates to spirocyclic amide derivatives of the formula I, pharmaceutically acceptable salts thereof, a process for their preparation, pharmaceutical compositions containing them, and their use in therapy.
    Type: Application
    Filed: April 2, 2012
    Publication date: December 20, 2012
    Inventors: Lilian Alcaraz, Andrew Bailey, Richard James Bull, Timothy Johnson, Nicholas David Kindon, Andrew Stuart Lister, Andrew James Robbins, Michael John Stocks, Barry John Teobald
  • Compounds
    Publication number: 20090298807
    Abstract: The present invention relates to spirocyclic amide derivatives of the formula I, pharmaceutically acceptable salts thereof, a process for their preparation, pharmaceutical compositions containing them, and their use in therapy.
    Type: Application
    Filed: February 4, 2009
    Publication date: December 3, 2009
    Inventors: Lilian Alcaraz, Andrew Bailey, Richard James Bull, Timothy Johnson, Nicholas David Kindon, Andrew Stuart Lister, Andrew James Robbins, Michael John Stocks, Barry John Teobald